The Strategic Advisory Team at Xalud Therapeutics provides expert guidance on long-term planning, market positioning, and partnership opportunities to optimize the development and commercialization of the company's non-viral gene therapy platform. Their collective expertise helps navigate regulatory landscapes, investment strategies, and scientific advancements to drive Xalud's mission forward.
Amy S. Chappell
Strategic Advisor
Eric Grigsby
Strategic Advisor
Jaspal Singh
Strategic Advisor
Lee Simon
Strategic Advisor
Leonardo Kapural
Strategic Advisor
Linda Watkins
Strategic Advisor
Mace Rothenberg
Strategic Advisor
Matt Walker
Strategic Advisor
Michael Ehlers
Strategic Advisor
Tarek Samad
Strategic Advisor
View all